Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Lechartier

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 20, 2015
Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosisBenoit Lechartier, Stewart T Cole
Antimicrobial Agents and Chemotherapy|August 29, 2012
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosisBenoit Lechartier, Ruben C Hartkoorn, Stewart T Cole
Revue Medicale Suisse|December 11, 2025
Adam Saint-Roch, Benoit Lechartier, Claudio Sartori, et al.
Swiss Medical Weekly|March 9, 2022
Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectivesBenoit Lechartier, Ari Chaouat, John-David Aubert, et al.
Revue Medicale Suisse|November 15, 2024
[Post-pulmonary embolism syndrome: Litterature review 2024]Nicolas Coquoz, Benoit Lechartier, Patrick Yerly, et al.
Revue Medicale Suisse|July 12, 2017
[How to handle a non-resolving pneumonia?]Benoit Lechartier, Maura Prella, Oriol Manuel, et al.
EMBO Molecular Medicine|January 10, 2014
Tuberculosis drug discovery in the post-post-genomic eraBenoit Lechartier, Jan Rybniker, Alimuddin Zumla, et al.
Revue Medicale Suisse|November 16, 2022
[Hypoxemia: from pathophysiology to diagnosis]Florence Coste, Argyro Vraka, Ivan Guerreiro, et al.
Seminars in Respiratory and Critical Care Medicine|August 18, 2023
Updated Hemodynamic Definition and Classification of Pulmonary HypertensionBenoit Lechartier, Mithum Kularatne, Xavier Jaïs, et al.
The European Respiratory Journal|June 16, 2022
Screening for pulmonary veno-occlusive disease in heterozygous <i>EIF2AK4</i> variant carriersBenoit Lechartier, Barbara Girerd, Mélanie Eyries, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 20, 2015
Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosisBenoit Lechartier, Stewart T Cole
Antimicrobial Agents and Chemotherapy|August 29, 2012
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosisBenoit Lechartier, Ruben C Hartkoorn, Stewart T Cole
Revue Medicale Suisse|December 11, 2025
Adam Saint-Roch, Benoit Lechartier, Claudio Sartori, et al.
Swiss Medical Weekly|March 9, 2022
Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectivesBenoit Lechartier, Ari Chaouat, John-David Aubert, et al.
Revue Medicale Suisse|November 15, 2024
[Post-pulmonary embolism syndrome: Litterature review 2024]Nicolas Coquoz, Benoit Lechartier, Patrick Yerly, et al.
Revue Medicale Suisse|July 12, 2017
[How to handle a non-resolving pneumonia?]Benoit Lechartier, Maura Prella, Oriol Manuel, et al.
EMBO Molecular Medicine|January 10, 2014
Tuberculosis drug discovery in the post-post-genomic eraBenoit Lechartier, Jan Rybniker, Alimuddin Zumla, et al.
Revue Medicale Suisse|November 16, 2022
[Hypoxemia: from pathophysiology to diagnosis]Florence Coste, Argyro Vraka, Ivan Guerreiro, et al.
Seminars in Respiratory and Critical Care Medicine|August 18, 2023
Updated Hemodynamic Definition and Classification of Pulmonary HypertensionBenoit Lechartier, Mithum Kularatne, Xavier Jaïs, et al.
The European Respiratory Journal|June 16, 2022
Screening for pulmonary veno-occlusive disease in heterozygous <i>EIF2AK4</i> variant carriersBenoit Lechartier, Barbara Girerd, Mélanie Eyries, et al.
Pageof 4